Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “GANGLIOSIDES”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,423 records · Page 79Linked to original sources

[Gangliosides of pig and human thymuses].

The ganglioside composition of thymuses from pigs of different age, of embryonal human thymus and of thymus from newborns was studied. Pig thymus was found to contain 8 ganglioside fractions, i. e. N-acetyl- and N-glycoloylneuraminosyllactosylceramides (GM3), N-acetyl- and N-glycoloylneuraminosylgangliotetraosylceramides (GM1), (N-acetylneuraminosyl, N-glycoloylneuraminosyl)- and di(N-glycoloylneuraminosyl)lactosylceramides (GD3), N-glycoloylneuraminosylgangliotriaosylceramide (GM2) and a fucoganglioside. The ganglioside spectrum of pig thymus did not change with ageing. In embryonal human thymus and in thymus of newborns four ganglioside fractions were determined, i.e. GM3, N-acetylneuraminosylneolactotetraosylceramide GM2 and GD3. A comparison of the experimental results with literature data suggests that ganglioside GD3 is a marker of immature lymphoid cells displaying a marked phylogenetic stability.

Aging↗

Ganglioside changes induced by tumor promoters in promotable JB6 mouse epidermal cells: antagonism by an antipromoter.

Since cell surface gangliosides have been implicated in the regulation of cell growth and differentiation and since tumor-promoting phorbol esters produce a number of membrane changes, the possibility was investigated that ganglioside changes may play a role in promotion of transformation in JB6 mouse epidermal cells. The studies showed that tumor-promoting but not non-promoting phorbol esters produced decreased precursor incorporation into disialoganglioside GD1b and an unknown ganglioside, Gx. These ganglioside responses to promoters were antagonized by the antipromoter retinoic acid, thus suggesting that alterations in ganglioside levels may be involved in promotion of transformation.

Animals↗

The effects of diisopropylphosphorofluoridate (DFP) on the ganglioside profile in the chicken (Gallus domesticus) hindbrain.

The ameliorative effect(s) of exogenous gangliosides on the development of organophosphorus ester-induced delayed neurotoxicity (OPIDN) suggests that administration of an organophosphorus delayed neurotoxicant could alter the endogenous ganglioside composition of nervous system tissue. To investigate this possibility, White Leghorn hens were injected subcutaneously with diisopropylphosphorofluoridate (DFP) at a dose of 1 mg/kg body weight and hindbrains (cerebella and brainstems) were removed for analysis of ganglioside concentrations at 4, 7, 14, or 21 days post-dosing. Treatment with DFP resulted in an increase in the proportion of GQ1b from day 4 to day 21 post-dosing which was significantly (p < 0.05) different from the control value at day 21. The proportion of GT1b increased in a similar manner over the 21 day period while the proportion of GD3 decreased over time. These progressive changes in ganglioside composition paralleled increasing hindlimb ataxia characteristic of OPIDN. In addition, the concentrations of protein, total lipid, total cholesterol, and lipid phosphorus in the chicken hindbrain were not affected by administration of DFP, indicating that the changes in ganglioside concentrations were not due to a non-specific effect on lipids.

Animals↗

Human tumor gangliosides inhibit murine immune responses in vivo.

Gangliosides which are shed by tumor cells clearly inhibit cellular immune responses in vitro. However, the immunosuppressive activity of these molecules have been more difficult to ascertain in vivo. Here we have adapted a murine model to determine the effects of tumor gangliosides in an in vivo microenvironment, the lymph node draining the site of stimulation by allogeneic cells. In this model, allogeneic splenocytes (BALB/c) are s.c. injected into C3H mice. The cellular immune response in the draining popliteal lymph nodes 4 days later is evidenced as an increase in lymph node mass (2-fold), lymphocyte number (6-fold), and lymphocyte DNA synthesis (6-fold). Purified human neuroblastoma gangliosides (10 nmol) coinjected with the stimulating allogeneic cells significantly suppressed this in vivo immune response. The increase in the lymph node mass was reduced by 65% (0.66 versus 1.89 mg), the increase in lymphocyte number (4.0 x 10(6) cells/node) was almost completely inhibited (1.1 x 10(6) cells/node), and in vitro [3H]thymidine uptake by the lymphocytes recovered in vivo was reduced by 80%. In contrast to the inhibition by tumor gangliosides, liposomes of cholesterol:lecithin were not inhibitory. Thus, tumor gangliosides, specifically, modulate cellular immune responses in vivo, which may contribute to the observed enhancement of tumor formation by these molecules.

Animals↗

Src family tyrosine kinase p53/56lyn, a serine kinase and Fc epsilon RI associate with alpha-galactosyl derivatives of ganglioside GD1b in rat basophilic leukemia RBL-2H3 cells.

The monoclonal antibody (mAb) AA4 recognizes two alpha-galactosyl derivatives of the GD1b ganglioside on rat mast cells and on the rat basophilic leukemia RBL-2H3 cultured cell line. Here we demonstrate that mAb AA4 coprecipitated both protein tyrosine and serine kinases. In contrast, a monoclonal antibody to the GD3 ganglioside did not coprecipitate any kinase activity. In kinase assays of mAb AA4 immunoprecipitates there were phosphorylated proteins of 71-80, 53/56, and 41/42 kDa. All proteins were phosphorylated on tyrosine, whereas the 71-80- and 41/42-kDa proteins were also phosphorylated on serine residues. The precipitation of these proteins by mAb AA4 correlated with the presence of the alpha-galactosyl derivatives of GD1b. The 53/56-kDa proteins were identified as the Src-related tyrosine kinase p53/56lyn. The presence of p53/56lyn in the mAb AA4 immunoprecipitates was specific and was observed when several different detergents were used. The same 71-80-kDa tyrosine-phosphorylated proteins were immunoprecipitated by mAb AA4 and anti-Lyn antibodies and may play a role in the interaction of p53/56lyn with the gangliosides. Although there is a weak association of the high affinity IgE receptor with these gangliosides, the coprecipitation of p53/56lyn with mAb AA4 was not secondary to the association of this kinase with receptor. These complexes of gangliosides and several proteins that include p53/56lyn, a serine kinase, and the high affinity IgE receptor could play an important role in receptor-mediated signal transduction.

Animals↗

[The effect of exogenous gangliosides on the formation in rats of instrumental movements with tactile control].

The process of learning and memorization of instrumental reaching movements with pressure on an operandum by a preferable forepaw were studied in white rats after ganglioside injections. The coursed of learning in control and ganglioside injected animals were shown to be alike while some ganglioside treated rats demonstrated increased motor activity. After a 5-week interval animals of both groups were able to perform quick reaching movements, but the storage of ability to push the operandum during the defined time was revealed only in ganglioside injected group. It may be considered that the ganglioside injections support the long-term storage of learned movements with tactile control.

Animals↗

Sugar-specific interaction of bovine brain beta-galactoside-binding lectin with endogenous gangliosides.

Sugar-specific binding of the 14 kDa beta-galactoside-binding lectin from bovine brain grey matter to mixed endogenous gangliosides was demonstrated by affinity electrophoresis and hemagglutination inhibition. Gangliosides prepared by Folch extraction, base treatment and silica gel chromatography, when incorporated in native or desialated form in polyacrylamide gel above their critical micellar concentration, arrested the mobility of the lectin during electrophoresis at pH 8.2. This effect was sugar-specific since it was reversed if lactose, but not sucrose, was present in the gel. Also, retention of the brain lectin by ganglioside and its reversal by lactose were concentration-dependent. In presence of bovine serum albumin, at pH 7.4 native and desialylated gangliosides equally inhibited agglutination of trypsinized rabbit red cells by bovine brain lectin, but not that by the alpha-galactoside-specific antibody from human serum. Results suggested the possibility of endogenous gangliosides acting as cell surface receptors in mediation of brain lectin function.

Animals↗

GM-1 ganglioside and motor recovery following human spinal cord injury.

Neurological deficit resulting from spinal cord injury varies widely in severity, ranging from transient abnormal reflexes to lifelong complete absence of motor and sensory function. Medical treatment to aid damaged neurons to recover function has been very limited; therapeutic efforts have focused primarily on initial stabilization of fractures, hemodynamic resuscitation, and then aggressive rehabilitation to enhance the full development of any remaining neuronal activity. Pharmacological treatment to improve restoration of neurological function may be possible, however, as indicated by many animal studies and a few clinical studies with a number of agents. A recent clinical trial of GM-1 ganglioside conducted in patients with spinal cord injuries showed that GM-1 ganglioside enhanced the recovery of neurological function 1 year after major spinal cord injury. In addition to GM-1 ganglioside treatment, these patients received aggressive medical and surgical treatment, as well as methylprednisolone. Neurological recovery was assessed with the Frankel scale and the American Spinal Injury Association (ASIA) motor scale. The findings show enhanced motor recovery compared with placebo in the lower extremities, but not in the upper extremities, over time. This corresponds to improved function of axons passing through the site of injury. Analysis of individual motor groups showed that neurological recovery in the GM-1 ganglioside-treated patients increased in initially paralyzed muscles, enabling them to regain useful motor function; paretic muscles were not found to be strengthened. The study provides the basis for larger studies of GM-1 ganglioside and methylprednisolone, which are currently under way.

Double-Blind Method↗

Kinetic and spatial interrelationships between ganglioside glycosyltransferases and O-acetyltransferase(s) in human melanoma cells.

The melanoma-associated disialogangliosides 9(7)-O-acetyl-GD3 and 9(7)-O-acetyl-GD2 have been structurally well characterized. However, the compartmentalization and sequence of action of the biosynthetic activities responsible for synthesizing these molecules remain obscure. Here, we have studied the spatial and temporal interrelationships among the activities responsible for the later stages of ganglioside biosynthesis and those for O-acetylation in cultured human melanoma cells. First, brefeldin A treatment was used to separate biosynthetic steps into compartments distal or proximal to the transport block imposed by the drug. In keeping with prior reports, GM2/GD2 synthase was consistently rendered inaccessible to its acceptors GM3 and GD3. In contrast, the effect on GD3 biosynthesis was cell line-specific. Synthesis of GD3 was nearly abrogated in two lines, while it accumulated in a third line. This indicates that the spatial organization of ganglioside processing activities can vary even between similar cell lines. However, in all cell lines studied, the ratio of 9(7)-O-acetyl-GD3 to GD3 was not changed by brefeldin A, indicating that the majority of ganglioside O-acetyltransferase activity is co-localized with GD3 biosynthetic activity in the same Golgi subcompartment(s). As an alternative approach, Golgi-enriched fractions from melanoma cells were incubated with radiolabeled and nonlabeled nucleotide sugars or acetyl-CoA. In these preparations, biosynthesis is dependent upon the co-localization of appropriate sugar nucleotide transporters, glycosyltransferases, and acceptors that are endogenously present within intact topologically correct compartments. Incubations with CMP-Neu5Ac and acetyl-CoA corroborated the results with brefeldin A, co-localizing ganglioside O-acetyltransferase activity in compartments where GD3 biosynthesis takes place. Analyses with CMP-Neu5Ac and UDP-GalNAc showed that GD2 and GD3 synthesis occur in partially overlapping compartments. Labeling with acetyl-CoA and UDP-GalNAc indicated that although labeled acetate can be transferred from acetyl-CoA directly to GD2, ganglioside O-acetyltransferase activity does not substantially overlap with the biosynthetic compartment(s) for GD2. Instead, O-acetyl-GD3 appears to be co-localized with the compartment of GD2 biosynthesis and serves as an acceptor for GD2 synthase. Thus, both 9-O-acetyl-GD3 and GD2 can be precursors of 9-O-acetyl-GD2, but apparently in distinct compartments.

Acetyltransferases↗

Abrogation of shedding of immunosuppressive neuroblastoma gangliosides.

Shedding of tumor cell gangliosides may contribute to tumor cell escape from host immune destruction. Thus, it would be of interest to block the shedding of these immunosuppressive molecules. To this end, we studied a ceramide analogue, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP). D-PDMP is a potent inhibitor of glucosylceramide synthase and thereby the synthesis of cellular glycosphingolipids. Exposure of LAN-5 human neuroblastoma cells to 10 microM D-PDMP for 5 days almost completely abolished the shedding of gangliosides (from 240 to 8 pmol/10(8) cells/h), whereas cellular ganglioside synthesis was reduced by 90%. A shorter (3-day) treatment of LAN-5 cells with 10 microM D-PDMP was already effective in inhibiting shedding (by 86%) even while the cellular ganglioside content was still high. Specificity was evidenced by the only minimal effect of D-PDMP on the synthesis of sphingomyelin and phosphatidylcholine. Therefore, certain pharmacological agents, such as D-PDMP, may be useful in abrogating tumor ganglioside shedding and its consequent biological effects in vivo.

Cell Division↗

Signal properties of brain gangliosides.

There are some data on gangliosides--sialo acid-containing complex glycolipids--showing that gangliosides due to their physicochemical properties and specific distribution are able to serve as specific signal molecules in different, evolutionary distant organisms. Individual gangliosides are widespread in the CNS, demonstrating variety of signalling mechanisms. These mechanisms have different degree of molecular complexity and are likely to be the object of natural evolution of gangliosides signal properties. The review summarises data on possible signal properties of gangliosides in terms of their complication and supposed evolution of mechanisms.

Animals↗

Correlation of expression of NCAM and GD3 ganglioside to motile behaviour in neoplastic glia.

Studies of developing mammalian tissues have established that certain neural cell adhesion molecules (NCAMs) may be down-regulated during the migratory phase concurrent with an increase in levels of matrix metalloproteinases. In addition, there is evidence that simple gangliosides such as GD3 are transiently present on the surface of such migratory cells. Since migration, or motility, is a prerequisite for diffuse local invasion of brain by neoplastic cells, the expression of NCAM and GD3 on brain tumour cells was studied in order to establish their possible role in the invasive process. An astrocytoma parent cell line (IPSB-18) and two morphologically distinct, cloned cell lines (clone 1 and 12) derived from it, were used in in vitro motility assays using 8 microns porosity polycarbonate filters in "Transwell" modified Boyden chambers. Immunocytochemical staining with anti-NCAM monoclonal antibodies (UJ13A and ERIC-1) and with the anti-ganglioside monoclonal antibodies LB1 (which recognises GD3) and A2B5 (which recognises a range of simple gangliosides) showed that some cells in culture from the parent line were positive for either NCAM or GD3; clone 1 was NCAM positive but GD3 negative, while clone 12 was NCAM negative but ganglioside positive. Motility assays showed that although clone 12 migrated more efficiently than either clone 1 or the parent line, this was not statistically significant. Moreover, similar assays were conducted on two further sub populations of cells which were evolved from the immunomagnetic separation of the parent cell line, IPSB-18, according to NCAM expression (i.e. NCAM positive and NCAM negative). The results indicated that the NCAM negative cells migrated more efficiently than the NCAM positive cells, in a time-dependent manner, when incubated for 4, 12 and 18 hours in Boyden chambers. These findings suggest that during the migratory phase of brain tumour invasion, NCAM expression is down-regulated whereas ganglioside expression is up-regulated.

Antibodies, Monoclonal↗

[Gangliosides prevent reduction in exploratory activity and delayed neuronal death in gerbils subjected to transitory cerebral ischemia].

INTRODUCTION: The ganglioside GM1 has been shown to be effective in the treatment of experimental cerebral ischemia. Gangliosides from bovine brain have not been used in the treatment of ischemic cerebral accidents. There is evidence suggesting that they may also be effective. RESULTS: Ten minutes of bilateral occlusion of the carotid arteries of Mongolian gerbils leads a week later to reduced spontaneous exploratory activity, assessed by counting the number of times they stood up in an open field over a period of three minutes, and retarded neuronal death in the pyramidal stratum of the CA1 sector of the hippocampus, evaluated on the density of normal neurons in this region of both hemispheres. Treatment with 30 mg/kg of intra-peritoneal bovine cerebral gangliosides during the first six days following occlusion of the carotid arteries, leads to conservation of both exploratory activity and density of pyramidal neurons observed in the control animals. CONCLUSIONS: Bovine cerebral gangliosides have a short term cytoprotector effect on neurons sensitive to the ischemia-reperfusion phenomenon. This effect may be due to more than one mechanism, in which other gangliosides (together with GM1) may be present due to transient permeability of the blood-brain barrier.

Animals↗

Epitope dissection of receptor-active gangliosides with affinity for Helicobacter pylori and influenza virus.

Receptor-active gangliosides with affinity for Helicobacter pylori and influenza virus were chemically modified and analyzed by negative ion fast atom bombardment mass spectrometry (FAB MS) or electron ionization mass spectrometry (EI MS) after permethylation. Derivatizations included mild periodate oxidation of the sialic acid glycerol tail or conversion of the carboxyl group to primary alcohol or amides. The modified gangliosides were then tested for binding affinity using thin-layer plates overlaid with labeled microbes or microbe-derived proteins. Mild periodate oxidation, which shortens sialic acid tail without destruction of sugar cores, abolished or drastically reduced binding of H. pylori and avian influenza virus to sialyl-3-paragloboside (S-3-PG). The same effect was observed in the case of binding of the human influenza virus to receptor-active gangliosides of human leukocytes. Conversion of S-3-PG or leukocyte gangliosides to primary alcohols or amides also abolished the binding. However, mild periodate oxidation had no effect on binding of NAP (neutrophil-activating protein of H. pylori) to the active ganglioside.

Binding Sites↗

Physiological concentrations of gangliosides GM1, GM2 and GM3 differentially modify basic-fibroblast-growth-factor-induced mitogenesis and the associated signalling pathway in endothelial cells.

It has been suggested that gangliosides can influence the growth of cells by modulation of growth-factor-receptor signalling. The activation of endothelial cells (EC) during angiogenesis is crucial for tumour growth and for metastasis, also for numerous other physiological and pathological situations. Pre-treatment of bovine aortic endothelial cells (BAEC) with GM1 or GM2 (5-20 microM) inhibited basic-fibroblast-growth-factor (bFGF)-induced mitogenesis, but GM3 (0.1-20 microM) acted synergistically, increasing proliferation above that of bFGF alone (p < 0.05). The mitogenic effect of all 3 gangliosides was markedly reduced if the cells were washed to remove excess gangliosides from the medium before addition of bFGF. We further show that GM1 and to a lesser extent GM2 modify bFGF binding to its receptor and inhibit the associated mitogenic signal-transduction pathway of protein-tyrosine phosphorylation of 40 to 120 kDa, PLCgamma1, MAP kinase and protein-kinase-C activation. In contrast, GM3 increased tyrosine phosphorylation and MAP kinase activity, as compared with bFGF alone. The observed differential modulation of bFGF-induced mitogenesis by GM1, GM2 and GM3 was at concentrations routinely occurring in the serum of cancer patients. The results suggest that circulating gangliosides may have a role in regulating solid-tumour growth by modulating angiogenesis.

Animals↗

GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.

Uptake of radioactivity from 14C-galactose into gangliosides by cultured skin fibroblasts was studied. GM3 was the major ganglioside in control human fibroblasts. An increase of GM1 was demonstrated in GM1-gangliosidosis fibroblasts. The degree of GM1 accumulation was correlated with the clinical types of this disease. The fibroblasts from an infantile-type patient showed a marked increase of GM1. In late-onset types the amount of total gangliosides was only slightly increased, but the distribution of individual gangliosides was definitely abnormal; a relative increase of GM1 was demonstrated in these cases. GM1 beta-galactosidase activities were not detectable in either infantile or late-onset cases.

Cells, Cultured↗

Prosaposin and prosaptide, a peptide from prosaposin, induce an increase in ganglioside content on NS20Y neuroblastoma cells.

Prosaposin has been recently identified as a neurotrophic factor eliciting differentiation in neuronal cultured cells (NS20Y). In this paper we investigate whether prosaposin and its active peptide (prosaptide) may modify the ganglioside pattern in neuroblastoma cells. The analysis by high performance thin layer chromatography did not reveal qualitative changes in the ganglioside pattern of NS20Y cells incubated in the presence of prosaposin, compared to control cells, but it did reveal an increase of the content of all three major resorcinol positive bands (GM3, GM2, GD1a). Cytofluorimetric and immunofluorescence microscopic analysis revealed that the increase of the ganglioside content was at the plasma membrane level. These findings suggest that the neurotrophic activity of prosaposin on NS20Y neuroblastoma cells might be mediated in part by the increase of cell surface gangliosides.

Animals↗

Internalization of exogenous gangliosides in cultured skin fibroblasts for the diagnosis of mucolipidosis IV.

The internalization of exogenous mixed brain gangliosides in ML IV cultured skin fibroblasts indicated an impairment of ganglioside catabolism in these cells. Incubation of ML IV, normal and various other lysosomal storage disorders cell lines for five days with exogenous tritium labelled GM3, GD1a or GT1 gangliosides allowed accurate quantitation of the retained gangliosides. This in vitro approach provides a reliable method for the diagnosis of ML IV.

Cells, Cultured↗